Timothy C. Dec - 04 May 2023 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Senior Vice-President & CFO
Signature
/s/ Timothy C. Dec
Issuer symbol
SUPN
Transactions as of
04 May 2023
Transactions value $
$0
Form type
4
Date filed
08 May 2023, 17:00
Previous filing
10 Apr 2023
Next filing
12 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SUPN Common Stock 1.86K 04 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Performance Share Units Award $0 +1.5K $0.00 1.5K 04 May 2023 Common Stock 1.5K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 3, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period.